AIFORIA TECHNOLOGIES OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.65 EUR | +1.31% |
|
+2.88% | +33.24% |
| Jun. 14 | Finland's Biohit Names Chief Technology Officer | MT |
| May. 15 | Aiforia Wins a Framework Agreement to Provide AI Solutions for Fimlab Laboratories in Finland | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 135.5 | 83.42 | 90.57 | 134.1 | - | - |
| Enterprise Value (EV) 1 | 135.5 | 61.41 | 81.55 | 119.9 | 129.5 | 134.1 |
| P/E ratio | - | -7.88 x | -6.98 x | -11.3 x | -12.9 x | -21.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 139 x | 44.7 x | 37.8 x | 31.2 x | 16.6 x | 9.45 x |
| EV / Revenue | 139 x | 32.9 x | 34 x | 27.9 x | 16 x | 9.45 x |
| EV / EBITDA | - | -7.57 x | -8.41 x | -17.1 x | -29.4 x | 268 x |
| EV / FCF | - | -3.9 x | -5.73 x | -60 x | -14.9 x | -27.4 x |
| FCF Yield | - | -25.6% | -17.4% | -1.67% | -6.72% | -3.65% |
| Price to Book | - | 2.85 x | 5.06 x | 5.47 x | 9.49 x | - |
| Nbr of stocks (in thousands) | 25,966 | 25,827 | 25,951 | 28,844 | - | - |
| Reference price 2 | 5.220 | 3.230 | 3.490 | 4.650 | 4.650 | 4.650 |
| Announcement Date | 3/3/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.974 | 1.868 | 2.398 | 4.3 | 8.1 | 14.2 |
| EBITDA 1 | - | -8.108 | -9.699 | -7 | -4.4 | 0.5 |
| EBIT 1 | - | -10.2 | -12.88 | -11.5 | -10.1 | -5.9 |
| Operating Margin | - | -546.2% | -537.07% | -267.44% | -124.69% | -41.55% |
| Earnings before Tax (EBT) 1 | - | -10.61 | -12.92 | -11.7 | -10.4 | -6.2 |
| Net income 1 | -7.576 | -10.61 | -12.92 | -11.7 | -10.4 | -6.2 |
| Net margin | -777.82% | -567.83% | -538.99% | -272.09% | -128.4% | -43.66% |
| EPS 2 | - | -0.4100 | -0.5000 | -0.4100 | -0.3600 | -0.2200 |
| Free Cash Flow 1 | - | -15.75 | -14.23 | -2 | -8.7 | -4.9 |
| FCF margin | - | -843.2% | -593.45% | -46.51% | -107.41% | -34.51% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/3/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.733 | 1.135 | 0.92 | 1.438 | 2 | 2.3 |
| EBITDA 1 | -3.51 | -4.597 | -4.749 | -4.616 | -3.5 | -3.4 |
| EBIT 1 | -4.389 | -5.814 | -6.182 | -6.363 | -5.6 | -5.9 |
| Operating Margin | -598.77% | -512.25% | -671.96% | -442.49% | -280% | -256.52% |
| Earnings before Tax (EBT) 1 | -4.38 | -6.227 | -6.254 | -6.413 | -5.7 | -6 |
| Net income 1 | -4.38 | -6.227 | -6.254 | -6.393 | -5.7 | -6 |
| Net margin | -597.54% | -548.63% | -679.78% | -444.58% | -285% | -260.87% |
| EPS 2 | -0.1700 | -0.2400 | -0.2400 | -0.2500 | -0.2000 | -0.2100 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/25/22 | 3/2/23 | 8/25/23 | 3/7/24 | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 22 | 9.01 | 14.2 | 4.6 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -15.8 | -14.2 | -2 | -8.7 | -4.9 |
| ROE (net income / shareholders' equity) | - | -31.6% | -54.8% | -45.4% | -54.1% | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 1.130 | 0.6900 | 0.8500 | 0.4900 | - |
| Cash Flow per Share 2 | - | -0.3600 | - | -0.2200 | -0.1300 | - |
| Capex 1 | - | 6.33 | 6.07 | 5.5 | 5.6 | 6.2 |
| Capex / Sales | - | 339.03% | 253.17% | 127.91% | 69.14% | 43.66% |
| Announcement Date | 3/3/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.65
EUR
Average target price
4.6
EUR
Spread / Average Target
-1.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +33.24% | 146M | |
| +19.25% | 94.08B | |
| +15.90% | 86.55B | |
| +63.45% | 62.51B | |
| -22.05% | 49.4B | |
| +38.19% | 48.66B | |
| -23.72% | 47.23B | |
| +82.30% | 42.4B | |
| -4.72% | 26.84B | |
| -11.35% | 25.94B |
- Stock Market
- Equities
- AIFORIA Stock
- Financials Aiforia Technologies Oyj
